Charlie's Holdings, Inc. (CHUC) stock
CHUCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.11+0.01 (+13.30%)
Close on Oct 19, 2026Market cap $31.05MP/E –Yield –
Charlie's revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Charlie's's revenue for the twelve months ending Jun 30, 2026 was $24.67M, up 310.5% year over year. For fiscal 2025 it was $20.92M, up 169.4% from the year before. Over ten years it grew 13.1% a year on average. The highest annual figure on record is $26.42M in fiscal 2022.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.92M | +169.4% |
| FY2024 | Dec 31, 2024 | $7.77M | -52.2% |
| FY2023 | Dec 31, 2023 | $16.25M | -38.5% |
| FY2022 | Dec 31, 2022 | $26.42M | +22.9% |
| FY2021 | Dec 31, 2021 | $21.50M | +28.8% |
| FY2020 | Dec 31, 2020 | $16.69M | -26.6% |
| FY2019 | Dec 31, 2019 | $22.74M | +9.1% |
| FY2018 | Dec 31, 2018 | $20.84M | +445.1% |
| FY2017 | Dec 31, 2017 | $3.82M | +48.5% |
| FY2016 | Dec 31, 2016 | $2.58M | -57.9% |
| FY2015 | Dec 31, 2015 | $6.12M | +30.4% |
| FY2014 | Dec 31, 2014 | $4.69M | +77.1% |
| FY2013 | Dec 31, 2013 | $2.65M | +159.3% |
| FY2012 | Dec 31, 2012 | $1.02M | -19.3% |
| FY2011 | Dec 31, 2011 | $1.27M | -44.3% |
| FY2010 | Dec 31, 2010 | $2.27M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $3.80M | +115.9% |
| Q1 FY2026 | Mar 31, 2026 | $4.80M | +204.4% |
| Q4 FY2025 | Dec 31, 2025 | $8.98M | +757.9% |
| Q3 FY2025 | Sep 30, 2025 | $7.08M | +336.2% |
| Q2 FY2025 | Jun 30, 2025 | $1.76M | -13.8% |
| Q1 FY2025 | Mar 31, 2025 | $1.58M | -48.3% |
| Q4 FY2024 | Dec 31, 2024 | $1.05M | -81.1% |
| Q3 FY2024 | Sep 30, 2024 | $1.62M | -40.0% |
| Q2 FY2024 | Jun 30, 2024 | $2.04M | -48.5% |
| Q1 FY2024 | Mar 31, 2024 | $3.05M | -24.3% |
| Q4 FY2023 | Dec 31, 2023 | $5.54M | +22.5% |
| Q3 FY2023 | Sep 30, 2023 | $2.71M | -57.9% |
| Q2 FY2023 | Jun 30, 2023 | $3.97M | -46.3% |
| Q1 FY2023 | Mar 31, 2023 | $4.03M | -50.1% |
| Q4 FY2022 | Dec 31, 2022 | $4.53M | -30.2% |
| Q3 FY2022 | Sep 30, 2022 | $6.43M | +23.1% |
| Q2 FY2022 | Jun 30, 2022 | $7.40M | +36.1% |
| Q1 FY2022 | Mar 31, 2022 | $8.07M | +85.1% |
| Q4 FY2021 | Dec 31, 2021 | $6.48M | +53.3% |
| Q3 FY2021 | Sep 30, 2021 | $5.22M | +34.0% |
| Q2 FY2021 | Jun 30, 2021 | $5.43M | +30.5% |
| Q1 FY2021 | Mar 31, 2021 | $4.36M | -1.0% |
| Q4 FY2020 | Dec 31, 2020 | $4.23M | +14.8% |
| Q3 FY2020 | Sep 30, 2020 | $3.89M | -30.3% |
| Q2 FY2020 | Jun 30, 2020 | $4.16M | -38.9% |
| Q1 FY2020 | Mar 31, 2020 | $4.41M | -33.7% |
| Q4 FY2019 | Dec 31, 2019 | $3.68M | -21.6% |
| Q3 FY2019 | Sep 30, 2019 | $5.59M | +7.0% |
| Q2 FY2019 | Jun 30, 2019 | $6.82M | +24.3% |
| Q1 FY2019 | Mar 31, 2019 | $6.65M | +2104.1% |
| Q4 FY2018 | Dec 31, 2018 | $4.70M | +356.2% |
| Q3 FY2018 | Sep 30, 2018 | $5.22M | +169.9% |
| Q2 FY2018 | Jun 30, 2018 | $5.49M | +258.6% |
| Q1 FY2018 | Mar 31, 2018 | $301.63K | -44.9% |
| Q3 FY2017 | Sep 30, 2017 | $1.03M | +7.1% |
| Q2 FY2017 | Jun 30, 2017 | $1.93M | – |
| Q1 FY2017 | Mar 31, 2017 | $1.53M | – |
| Q4 FY2016 | Dec 31, 2016 | $547.23K | – |
| Q3 FY2016 | Sep 30, 2016 | $961.95K | – |
See a number that looks wrong?